Skip to content

DBV Technologies DBVT Total Revenue

Total Revenue at other companies

Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$15K-97.8%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$10.86M+3.8%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$34.37M+55.5%
Alumis Inc. logo
Alumis Inc.ALMS
$1.74M-90.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$3.61B+19.0%
Incyte logo
IncyteINCY
$1.27B+20.9%

Other financials

Income statement

See full
Operating income-$47.9M-80.1%
Net income-$47.6M-75.6%
EPS (diluted)-$0.11+57.7%

Balance sheet

See full
Cash & equivalents$229.2M+1,668%
Total debt$6.1M-15.7%
Total equity$207.9M+7,069%
Total assets$266.4M+427%

Cash flow

See full
Operating cash flow-$49.1M-149%
CapEx$400.0K
Free cash flow-$49.5M-151%

Valuation

See full
Market cap$923.31M+259%
Enterprise value$700.21M+179%
P/S159.6×+87.1×

Profitability

See full
Operating margin-2,910.4%-265pp
Net margin-2,895.4%-257pp
FCF margin-2,619.5%+69.9pp

Returns & leverage

See full
Return on equity-158.9%-26.4pp
Debt / equity-2.5×
Current ratio4.8×+4.0×

Where this comes from

Reported directly by DBV Technologies in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: DBV Technologies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DBV Technologies's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DBV Technologies's total revenue?
DBV Technologies (DBVT) reported total revenue of $900K in Q1 2026.
How has DBV Technologies's total revenue changed year-over-year?
DBV Technologies's total revenue increased by 12.5% year-over-year, from $800K to $900K.
What is the long-term trend for DBV Technologies's total revenue?
Over 3 years (2021 to 2025), DBV Technologies's total revenue has grown at a -0.1% compound annual growth rate (CAGR), from $5.71M to $5.68M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.